A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic Dermatitis
Astellas Pharma Inc
The purpose of the study is to determine the impact of topical corticosteroids on the safety
and effectiveness of Protopic Ointment in the short-term treatment of moderate to severe
Atopic Dermatitis and to compare the safety and effectiveness of Protopic Ointment to
placebo in the long-term management of Atopic Dermatitis
Epiceram Versus Elidel for Treatment of Mild to Moderate Atopic Dermatitis
Atopic dermatitis (AD) is a common skin disease that has increased in prevalence worldwide
two- to threefold over the last 50 years. Epiceram, a newly FDA-approved medical device is a
topical barrier repair cream designed to deliver special epidermal lipids to the top layers
of the skin in order to correct skin barrier abnormalities found in atopic dermatitis.
Epiceram does not contain corticosteroids or other conventional anti-inflammatory components
and represents a novel class of skin barrier repair therapy for inflammatory skin disease.
The objective of this study is to determine whether Epiceram is a safe and effective therapy
for mild to moderate atopic dermatitis and whether it may serve as an alternative to Elidel
Clinical Trial to Assess the Efficacy and Safety of Tacrolimus Ointment Treatment of Atopic Dermatitis in Adult Patients
Astellas Pharma Inc
Objective: Assess efficacy and safety of tacrolimus ointment when used in adults with
moderate or severe atopic dermatitis. The ointment was applied on the affected skin twice
daily for 3 weeks and then once daily until all lesions were cleared
Patients who have participated in previous studies with Tacrolimus ointment for atopic
eczema are entitled to enter this four-year follow study to investigate the safety of
treatment with Tacrolimus ointment 0.1%
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.